Drug Act 1976 action urged after Sindh batch fails
Sindh government chemists rejected seven lots from six familiar brands after finding missing active compounds, and papers have gone to Karachi South’s drug inspector.
Sindh’s government lab rejected seven lots spanning six familiar brands after finding no usable active compounds.
Named lots include Velosef 500mg LX3A, Augmentin 526mg YT9D, Brufen W6BC, and Laxoberon syrup 46292 and 43445.
No-Spa Forte and Mucaine Suspension lots also missed the lab’s required standards.
Martin Dow Marker said it did not make the disputed Laxoberon lots; other firms likewise rejected the lots as theirs.
Findings went to the Quality Control Board Sindh secretary and the Drug Inspector Karachi South, with Drug Act 1976 steps advised.